The deletion of TRAIL was found to inhibit neo‐angiogenesis, pericyte recruitment, and vessel stabilization, ultimately leading to diminished blood perfusion in the lower limbs affected by ischemia [42]. The gene discussed is TNFSF10; the disease is ischemia.